- Home
- BLTE vs ERO Comparison
BLTE vs ERO Comparison
Compare BLTE & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- ERO
- Stock Information
- Founded
- BLTE 2018
- ERO 2016
- Country
- BLTE United States
- ERO Canada
- Employees
- BLTE N/A
- ERO N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- BLTE Health Care
- ERO
- Exchange
- BLTE Nasdaq
- ERO Nasdaq
- Market Cap
- BLTE 2.1B
- ERO 1.9B
- IPO Year
- BLTE 2022
- ERO N/A
- Fundamental
- Price
- BLTE $82.46
- ERO $15.89
- Analyst Decision
- BLTE Strong Buy
- ERO
- Analyst Count
- BLTE 4
- ERO 0
- Target Price
- BLTE $89.00
- ERO N/A
- AVG Volume (30 Days)
- BLTE 107.6K
- ERO 396.1K
- Earning Date
- BLTE 11-12-2024
- ERO 11-05-2024
- Dividend Yield
- BLTE N/A
- ERO N/A
- EPS Growth
- BLTE N/A
- ERO N/A
- EPS
- BLTE N/A
- ERO 0.17
- Revenue
- BLTE N/A
- ERO $464,134,000.00
- Revenue This Year
- BLTE N/A
- ERO $45.00
- Revenue Next Year
- BLTE N/A
- ERO $71.17
- P/E Ratio
- BLTE N/A
- ERO $94.88
- Revenue Growth
- BLTE N/A
- ERO 8.51
- 52 Week Low
- BLTE $31.01
- ERO $11.96
- 52 Week High
- BLTE $86.53
- ERO $24.34
- Technical
- Relative Strength Index (RSI)
- BLTE 72.06
- ERO 34.67
- Support Level
- BLTE $80.00
- ERO $16.40
- Resistance Level
- BLTE $84.50
- ERO $16.60
- Average True Range (ATR)
- BLTE 4.46
- ERO 0.64
- MACD
- BLTE -0.22
- ERO -0.04
- Stochastic Oscillator
- BLTE 83.18
- ERO 18.85
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.